TECTONIC THERAPEUTIC, INC. Capital Expenditures Incurred but Not yet Paid
TECTONIC THERAPEUTIC, INC. (TECX) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2023-11-09
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-09-30 was $0.00.
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-06-30 was $0.00.
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for the quarter ending 2022-09-30 was -$73.00K, a 121.73% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for fiscal 2019 was $582.00K, a 127.34% increase from fiscal 2018.
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for fiscal 2018 was $256.00K, a 2227.27% increase from fiscal 2017.
- TECTONIC THERAPEUTIC, INC. capital expenditures incurred but not yet paid for fiscal 2017 was $11.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2022-09-30 | -$73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$117.00K derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $73.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $117.00K 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | $336.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $465.00K derived: sum of 2 quarters · filed 2022-11-08 | $507.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $171.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $42.00K 10-Q · filed 2022-05-10 | |||
| 2019-12-31 | $502.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $572.00K derived: sum of 2 quarters · filed 2021-03-18 | $246.00K derived: sum of 3 quarters · filed 2021-03-18 | $582.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | $70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$256.00K derived: sum of 2 quarters · filed 2020-11-05 | $80.00K 10-Q · filed 2020-11-05 | $100.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$326.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.00K 10-Q · filed 2019-08-08 | $30.00K derived: sum of 3 quarters · filed 2020-03-16 | -$490.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | $336.00K 10-Q · filed 2019-05-13 | $356.00K derived: sum of 2 quarters · filed 2020-03-16 | -$164.00K derived: sum of 3 quarters · filed 2020-03-16 | $504.00K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$500.00K derived: sum of 2 quarters · filed 2020-03-16 | $168.00K derived: sum of 3 quarters · filed 2020-03-16 | $256.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | -$520.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $148.00K derived: sum of 2 quarters · filed 2019-11-07 | $236.00K 10-Q · filed 2019-11-07 | $211.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $668.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $756.00K 10-Q · filed 2019-08-08 | $731.00K derived: sum of 3 quarters · filed 2019-08-08 | $527.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $88.00K 10-Q · filed 2019-05-13 | $63.00K derived: sum of 2 quarters · filed 2019-05-13 | -$141.00K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$229.00K derived: sum of 2 quarters · filed 2019-03-25 | $11.00K 10-K · filed 2019-03-25 | |
| 2017-09-30 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $36.00K 10-Q · filed 2018-11-13 | ||
| 2017-06-30 | $240.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |